Lv51
1555 积分 2020-10-02 加入
Translating Preclinical Studies into the Clinic: Assays and Endpoints Selected to Determine Efficacy
17天前
已关闭
The MEK–RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancers
18天前
已关闭
Rewriting lysine reactivity: Lysine-targeted bioconjugation via biomimetic polarity reversal for diversified biomolecule modification
18天前
已关闭
When Checkpoint Inhibitors Break Barriers: Mechanisms and Challenges of irAEs of the Skin, Gastrointestinal Tract, and Lung
18天前
已关闭
Translating Preclinical Studies into the Clinic: Assays and Endpoints Selected to Determine Efficacy
18天前
已关闭
Causes of Death in Patients with Cancer: A Scoping Review
18天前
已关闭
Lessons learned in linking PROTACs from discovery to the clinic
18天前
已关闭
Toxicities From Antibody-Drug Conjugates
24天前
已完结
An overview of KRAS G12D inhibitors: Expanding the therapeutic frontier of KRAS in targeting KRAS G12D using diverse therapeutic modalities
1个月前
已关闭
Advances in Novel Modification Strategies for Enhancing the Tumor Tissue Specificity of PROTACs
1个月前
已关闭
皖公网安备34019202002308
